Cholera toll in Odisha's Jajpur rises to 5

Bhubaneswar/Jajpur, The cholera toll in Odisha's Jajpur district rose to five with one more person succumbing to the disease, an official said on Saturday.
The Jajpur district administration has cancelled Raja festival holidays for government officials as fresh cases were reported from three different places.
"In view of the cholera outbreak in different parts of the district, the holidays from June 14 to 16 are hereby cancelled. All offices in Jajpur district will remain open as usual and the services of employees will be utilised in case of exigency," the order issued by the district collector said.
Chief District Medical Officer Prakash Chandra Bal said the cholera toll rose to five with one more fatality reported on Friday.
Public Health Director Dr Nilakant Mishra said that of the 41 stool samples collected from patients, eight tested positive for cholera in Jajpur district. However, he said that the situation is under control due to widespread awareness, field-level prevention, and early detection and treatment.
Chief Secretary Manoj Ahuja, who reviewed the situation on Friday, directed the administrations of neighbouring districts to remain alert on the spread of the waterborne disease. He directed health authorities to step up measures to prevent and control the spread of waterborne diseases such as cholera, diarrhoea, jaundice, malaria, and dengue after the onset of monsoon.
Ahuja also directed officials to complete sanitation work within ten days and make all programmes for prevention, control, and management of water and vector-borne diseases more proactive and targeted. He also suggested the district administration to conduct house-to-house surveys to detect diseases, increase beds in government hospitals, ensure proper treatment and provide necessary medicines and saline.
The chief secretary also directed the Health and Family Welfare department to use mobile health units to make people aware of the water-borne diseases.
Officials said that over 750 people across the district have been affected by water-borne disease in the last four days. Among them, nearly 300 patients are currently undergoing treatment at different hospitals in the district while as many as 450 patients have been discharged from their respective hospitals after treatment.
Stating that the situation is gradually improving, the CDMO said while over 450 patients have returned home after treatment in the last three days, around 20 new patients have been admitted on Friday. About 30 critically ill patients are under treatment at SCB Medical College and Hospital, Cuttack from the district, he said.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Deccan Herald

2 days ago

• Deccan Herald

Karnataka Cabinet decides to relook into functioning of KAT

The Cabinet also approved a proposal by the Health and Family Welfare Department to provide cashless treatment worth Rs 5 lakh to three lakh contract workers in government departments and their dependents through the Suvarna Arogya Suraksha Trust.

Time of India

4 days ago

• Time of India

Influx Healthtech IPO opens today: Check key details before subscribing

Influx Healthtech, a Mumbai-based contract development and manufacturing organisation (CDMO), will open its initial public offering (IPO) for subscription today. The issue will close on June 20. The company aims to raise Rs 55.63 crore through a combination of fresh issue (Rs 45.07 crore) and an offer-for-sale (Rs 10.56 crore). The IPO is being offered in a price band of Rs 91 to Rs 96 per share. Investors can bid for a minimum of 1,200 shares It is proposed to list on the NSE SME platform, with a tentative listing date set for June 25. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Promoções imperdíveis de voos baratos Voos | Anúncios de Pesquisa Saiba Mais Undo Influx Healthtech operates in the health and wellness segment, offering a diverse range of services including product development and third-party manufacturing across nutraceuticals, cosmetics, ayurvedic products, and veterinary feed supplements. The company's facilities in Thane manufacture an expansive product portfolio ranging from tablets, gummies, and jellies to skincare and ayurvedic solutions. The IPO proceeds will primarily be used for setting up two new manufacturing units in the nutraceutical and veterinary segments (Rs 34.19 crore), along with machinery purchases and general corporate purposes. Live Events The company's revenue for FY25 stood at Rs 104.99 crore with a net profit of Rs 13.37 crore. ( Disclaimer : Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Economic Times)

Economic Times

4 days ago

• Economic Times

Influx Healthtech IPO opens today: Check key details before subscribing

Influx Healthtech, a Mumbai-based contract development and manufacturing organisation (CDMO), will open its initial public offering (IPO) for subscription today. The issue will close on June 20. The company aims to raise Rs 55.63 crore through a combination of fresh issue (Rs 45.07 crore) and an offer-for-sale (Rs 10.56 crore). ADVERTISEMENT The IPO is being offered in a price band of Rs 91 to Rs 96 per share. Investors can bid for a minimum of 1,200 shares It is proposed to list on the NSE SME platform, with a tentative listing date set for June 25. Influx Healthtech operates in the health and wellness segment, offering a diverse range of services including product development and third-party manufacturing across nutraceuticals, cosmetics, ayurvedic products, and veterinary feed supplements. The company's facilities in Thane manufacture an expansive product portfolio ranging from tablets, gummies, and jellies to skincare and ayurvedic IPO proceeds will primarily be used for setting up two new manufacturing units in the nutraceutical and veterinary segments (Rs 34.19 crore), along with machinery purchases and general corporate company's revenue for FY25 stood at Rs 104.99 crore with a net profit of Rs 13.37 crore. ADVERTISEMENT (Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)